Assignee
ABLEVIA BIOTECH GMBH
AT·2 granted patents·8 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
10 records- 0163US2024325560A1Compound for the sequestration of undesirable antibodies in a patientABLEVIA BIOTECH GMBH·Filed 2024·Application pending·0 cites
- 0254US11986536B2Compound for the sequestration of undesirable antibodies in a patientABLEVIA BIOTECH GMBH·Filed 2021·Granted May 21, 2024·0 cites·15 claims
- 0353US2025213707A1Compound for increasing efficacy of oncolytic virusesABLEVIA BIOTECH GMBH·Filed 2023·Application pending·0 cites
- 0445US2023355784A1Compound for the prevention or treatment of autoantibody-mediated conditionsABLEVIA BIOTECH GMBH·Filed 2021·Application pending·0 cites
- 0545US2023355660A1Compound for the sequestration of undesirable anti-peg antibodies in a patientABLEVIA BIOTECH GMBH·Filed 2021·Application pending·0 cites
- 0645US2023381334A1Compound for the sequestration of undesirable antibodies in a patientABLEVIA BIOTECH GMBH·Filed 2021·Application pending·0 cites
- 0745US2023355747A1Compound for increasing efficacy of viral vectorsABLEVIA BIOTECH GMBH·Filed 2021·Application pending·0 cites
- 0845US2023381328A1Compound for the prevention or treatment of myasthenia gravisABLEVIA BIOTECH GMBH·Filed 2021·Application pending·0 cites
- 0945US2023365655A1Compound for increasing the efficacy of factor viii replacement therapyABLEVIA BIOTECH GMBH·Filed 2021·Application pending·0 cites
- 1040US12011484B2Compound for the sequestration of undesirable antibodies in a patientABLEVIA BIOTECH GMBH·Filed 2020·Granted Jun 18, 2024·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when ABLEVIA BIOTECH GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →